Sign in
EP-1229: Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC)
Journal article   Open access  Peer reviewed

EP-1229: Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC)

O. Hansen, M. Knap, A. Khalil, C. Nyhus, C. Brink, L. Hoffmann and T. Schytte
Radiotherapy and oncology, Vol.123, pp.S663-S663
05/2017
url
https://doi.org/10.1016/S0167-8140(17)31664-XView
Published (Version of record) Open

Metrics

1 Record Views

Details